nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Carboplatin—uterine cancer	0.682	1	CbGbCtD
Propylthiouracil—Erythema nodosum—Progesterone—uterine cancer	0.0106	0.0457	CcSEcCtD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFE2L2—uterine cancer	0.00981	0.113	CbGpPWpGaD
Propylthiouracil—Erythema nodosum—Medroxyprogesterone Acetate—uterine cancer	0.00956	0.0414	CcSEcCtD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—GPX3—uterine cancer	0.00935	0.107	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.00819	0.094	CbGpPWpGaD
Propylthiouracil—Pigmentation disorder—Etoposide—uterine cancer	0.007	0.0303	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—INHBA—uterine cancer	0.00668	0.0767	CbGpPWpGaD
Propylthiouracil—Neuritis—Progesterone—uterine cancer	0.00611	0.0264	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—GPX3—uterine cancer	0.00566	0.065	CbGpPWpGaD
Propylthiouracil—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00554	0.024	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Etoposide—uterine cancer	0.00483	0.0209	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Epirubicin—uterine cancer	0.00392	0.017	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Progesterone—uterine cancer	0.00388	0.0168	CcSEcCtD
Propylthiouracil—Hepatic failure—Progesterone—uterine cancer	0.00369	0.016	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—uterine cancer	0.00363	0.0157	CcSEcCtD
Propylthiouracil—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00334	0.0145	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Etoposide—uterine cancer	0.0033	0.0143	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Dactinomycin—uterine cancer	0.00303	0.0131	CcSEcCtD
Propylthiouracil—Erythema nodosum—Epirubicin—uterine cancer	0.00303	0.0131	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.00291	0.0334	CbGpPWpGaD
Propylthiouracil—Erythema nodosum—Doxorubicin—uterine cancer	0.0028	0.0121	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—SOCS3—uterine cancer	0.00261	0.0299	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Dactinomycin—uterine cancer	0.00261	0.0113	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—GPX3—uterine cancer	0.00257	0.0295	CbGpPWpGaD
Propylthiouracil—Drowsiness—Progesterone—uterine cancer	0.00255	0.011	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Progesterone—uterine cancer	0.0025	0.0108	CcSEcCtD
Propylthiouracil—Jaundice—Progesterone—uterine cancer	0.00249	0.0108	CcSEcCtD
Propylthiouracil—Body temperature increased—Carboplatin—uterine cancer	0.00245	0.0106	CcSEcCtD
Propylthiouracil—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.01	CcSEcCtD
Propylthiouracil—Haemoglobin—Progesterone—uterine cancer	0.0023	0.00997	CcSEcCtD
Propylthiouracil—Hepatitis—Progesterone—uterine cancer	0.00229	0.00992	CcSEcCtD
Propylthiouracil—Haemorrhage—Progesterone—uterine cancer	0.00229	0.00992	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—CCL2—uterine cancer	0.00228	0.0261	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.00981	CcSEcCtD
Propylthiouracil—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00976	CcSEcCtD
Propylthiouracil—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00903	CcSEcCtD
Propylthiouracil—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00899	CcSEcCtD
Propylthiouracil—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00899	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—GPX3—uterine cancer	0.00204	0.0234	CbGpPWpGaD
Propylthiouracil—Alopecia—Progesterone—uterine cancer	0.00203	0.00876	CcSEcCtD
Propylthiouracil—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00794	CcSEcCtD
Propylthiouracil—Vertigo—Progesterone—uterine cancer	0.00179	0.00776	CcSEcCtD
Propylthiouracil—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00766	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—uterine cancer	0.00175	0.00758	CcSEcCtD
Propylthiouracil—Arthralgia—Progesterone—uterine cancer	0.0017	0.00735	CcSEcCtD
Propylthiouracil—Myalgia—Progesterone—uterine cancer	0.0017	0.00735	CcSEcCtD
Propylthiouracil—Agranulocytosis—Dactinomycin—uterine cancer	0.00168	0.00729	CcSEcCtD
Propylthiouracil—Skin ulcer—Epirubicin—uterine cancer	0.00168	0.00727	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—CCL2—uterine cancer	0.00164	0.0188	CbGpPWpGaD
Propylthiouracil—Oedema—Progesterone—uterine cancer	0.00163	0.00705	CcSEcCtD
Propylthiouracil—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00703	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—uterine cancer	0.00162	0.00702	CcSEcCtD
Propylthiouracil—Hepatitis—Dactinomycin—uterine cancer	0.00162	0.00701	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.00162	0.0186	CbGpPWpGaD
Propylthiouracil—Ageusia—Epirubicin—uterine cancer	0.00162	0.00699	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—uterine cancer	0.00156	0.00673	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—uterine cancer	0.00156	0.00673	CcSEcCtD
Propylthiouracil—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00666	CcSEcCtD
Propylthiouracil—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00666	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—uterine cancer	0.00149	0.00647	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00148	0.00642	CcSEcCtD
Propylthiouracil—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00638	CcSEcCtD
Propylthiouracil—Paraesthesia—Progesterone—uterine cancer	0.00146	0.00633	CcSEcCtD
Propylthiouracil—Somnolence—Progesterone—uterine cancer	0.00145	0.00626	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00625	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—uterine cancer	0.00144	0.00623	CcSEcCtD
Propylthiouracil—Dyspepsia—Progesterone—uterine cancer	0.00143	0.0062	CcSEcCtD
Propylthiouracil—Alopecia—Dactinomycin—uterine cancer	0.00143	0.00619	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—uterine cancer	0.00136	0.0156	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00582	CcSEcCtD
Propylthiouracil—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00573	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—MTHFR—uterine cancer	0.00132	0.0151	CbGpPWpGaD
Propylthiouracil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00568	CcSEcCtD
Propylthiouracil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00562	CcSEcCtD
Propylthiouracil—Urticaria—Progesterone—uterine cancer	0.00129	0.0056	CcSEcCtD
Propylthiouracil—Body temperature increased—Progesterone—uterine cancer	0.00129	0.00557	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Etoposide—uterine cancer	0.00128	0.00554	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—uterine cancer	0.00127	0.00551	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—CCL2—uterine cancer	0.00127	0.0145	CbGpPWpGaD
Propylthiouracil—Leukopenia—Dactinomycin—uterine cancer	0.00126	0.00546	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Epirubicin—uterine cancer	0.00123	0.00532	CcSEcCtD
Propylthiouracil—Agranulocytosis—Etoposide—uterine cancer	0.00122	0.00527	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NDUFB11—uterine cancer	0.00122	0.014	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SRD5A2—uterine cancer	0.00122	0.014	CbGpPWpGaD
Propylthiouracil—Myalgia—Dactinomycin—uterine cancer	0.0012	0.00519	CcSEcCtD
Propylthiouracil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00507	CcSEcCtD
Propylthiouracil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00505	CcSEcCtD
Propylthiouracil—Pruritus—Progesterone—uterine cancer	0.00115	0.00498	CcSEcCtD
Propylthiouracil—Oedema—Dactinomycin—uterine cancer	0.00115	0.00498	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—uterine cancer	0.00114	0.00492	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Dactinomycin—uterine cancer	0.00113	0.00488	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Epirubicin—uterine cancer	0.00111	0.00482	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—uterine cancer	0.00106	0.00457	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00105	0.00454	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—MTHFR—uterine cancer	0.00105	0.012	CbGpPWpGaD
Propylthiouracil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00452	CcSEcCtD
Propylthiouracil—Alopecia—Etoposide—uterine cancer	0.00104	0.00448	CcSEcCtD
Propylthiouracil—Vomiting—Progesterone—uterine cancer	0.00104	0.00448	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—CCL2—uterine cancer	0.00103	0.0118	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Doxorubicin—uterine cancer	0.00103	0.00446	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—uterine cancer	0.00103	0.00445	CcSEcCtD
Propylthiouracil—Rash—Progesterone—uterine cancer	0.00103	0.00444	CcSEcCtD
Propylthiouracil—Dermatitis—Progesterone—uterine cancer	0.00103	0.00444	CcSEcCtD
Propylthiouracil—Headache—Progesterone—uterine cancer	0.00102	0.00441	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00101	0.00436	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—uterine cancer	0.001	0.00432	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—uterine cancer	0.000978	0.00423	CcSEcCtD
Propylthiouracil—Nausea—Progesterone—uterine cancer	0.000967	0.00418	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—uterine cancer	0.000952	0.00412	CcSEcCtD
Propylthiouracil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00406	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000932	0.00403	CcSEcCtD
Propylthiouracil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00403	CcSEcCtD
Propylthiouracil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00402	CcSEcCtD
Propylthiouracil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000924	0.004	CcSEcCtD
Propylthiouracil—Vertigo—Etoposide—uterine cancer	0.000917	0.00397	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—uterine cancer	0.000914	0.00395	CcSEcCtD
Propylthiouracil—Body temperature increased—Dactinomycin—uterine cancer	0.00091	0.00394	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—STAR—uterine cancer	0.000879	0.0101	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKR1B1—uterine cancer	0.000879	0.0101	CbGpPWpGaD
Propylthiouracil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00379	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—uterine cancer	0.000822	0.00943	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—CCL2—uterine cancer	0.000819	0.0094	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Etoposide—uterine cancer	0.000816	0.00353	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—uterine cancer	0.000748	0.00324	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SRD5A2—uterine cancer	0.000743	0.00853	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NDUFB11—uterine cancer	0.000743	0.00853	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000741	0.0085	CbGpPWpGaD
Propylthiouracil—Somnolence—Etoposide—uterine cancer	0.000741	0.0032	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—uterine cancer	0.000732	0.00317	CcSEcCtD
Propylthiouracil—Vomiting—Dactinomycin—uterine cancer	0.000732	0.00317	CcSEcCtD
Propylthiouracil—Rash—Dactinomycin—uterine cancer	0.000726	0.00314	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—uterine cancer	0.000718	0.0031	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—uterine cancer	0.000714	0.00309	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SRD5A2—uterine cancer	0.000699	0.00802	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NDUFB11—uterine cancer	0.000699	0.00802	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—POLD1—uterine cancer	0.00069	0.00792	CbGpPWpGaD
Propylthiouracil—Nausea—Dactinomycin—uterine cancer	0.000684	0.00296	CcSEcCtD
Propylthiouracil—Agranulocytosis—Epirubicin—uterine cancer	0.000683	0.00296	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—uterine cancer	0.000677	0.00293	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000664	0.00287	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—uterine cancer	0.000662	0.00286	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—uterine cancer	0.000661	0.00286	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—uterine cancer	0.00066	0.00286	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—uterine cancer	0.000659	0.00285	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—uterine cancer	0.000657	0.00284	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—uterine cancer	0.000657	0.00284	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000656	0.00753	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKR1C1—uterine cancer	0.000645	0.00741	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Doxorubicin—uterine cancer	0.000632	0.00274	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—uterine cancer	0.000611	0.00264	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—uterine cancer	0.000608	0.00263	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—uterine cancer	0.000608	0.00263	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—uterine cancer	0.000589	0.00255	CcSEcCtD
Propylthiouracil—Alopecia—Epirubicin—uterine cancer	0.000581	0.00251	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—EP300—uterine cancer	0.000576	0.00661	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—RRM2—uterine cancer	0.000575	0.0066	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—uterine cancer	0.00056	0.00242	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—DCN—uterine cancer	0.000558	0.00641	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—uterine cancer	0.000539	0.00619	CbGpPWpGaD
Propylthiouracil—Alopecia—Doxorubicin—uterine cancer	0.000537	0.00232	CcSEcCtD
Propylthiouracil—DBH—Metabolism—AKR1B1—uterine cancer	0.000537	0.00616	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—STAR—uterine cancer	0.000537	0.00616	CbGpPWpGaD
Propylthiouracil—Vomiting—Etoposide—uterine cancer	0.00053	0.00229	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP11A1—uterine cancer	0.000526	0.00604	CbGpPWpGaD
Propylthiouracil—Rash—Etoposide—uterine cancer	0.000525	0.00227	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—uterine cancer	0.000525	0.00227	CcSEcCtD
Propylthiouracil—Headache—Etoposide—uterine cancer	0.000522	0.00226	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—uterine cancer	0.000518	0.00224	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—uterine cancer	0.000514	0.00222	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—uterine cancer	0.000512	0.00222	CcSEcCtD
Propylthiouracil—TPO—Metabolism—AKR1B1—uterine cancer	0.000505	0.00579	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—STAR—uterine cancer	0.000505	0.00579	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—uterine cancer	0.0005	0.00574	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKR1C3—uterine cancer	0.000497	0.0057	CbGpPWpGaD
Propylthiouracil—Nausea—Etoposide—uterine cancer	0.000495	0.00214	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—uterine cancer	0.000487	0.00211	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—uterine cancer	0.000487	0.00211	CcSEcCtD
Propylthiouracil—Vertigo—Doxorubicin—uterine cancer	0.000476	0.00206	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—uterine cancer	0.000474	0.00205	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—uterine cancer	0.000467	0.00202	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—uterine cancer	0.000464	0.00533	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Epirubicin—uterine cancer	0.000457	0.00198	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—uterine cancer	0.000451	0.00195	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—uterine cancer	0.000451	0.00195	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—uterine cancer	0.000432	0.00187	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000425	0.00184	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—uterine cancer	0.000423	0.00183	CcSEcCtD
Propylthiouracil—DBH—Metabolism—POLD1—uterine cancer	0.000422	0.00484	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Epirubicin—uterine cancer	0.000419	0.00181	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—uterine cancer	0.000415	0.0018	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—uterine cancer	0.000411	0.00178	CcSEcCtD
Propylthiouracil—TPO—Metabolism—POLD1—uterine cancer	0.000396	0.00455	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—uterine cancer	0.000395	0.00453	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKR1C1—uterine cancer	0.000394	0.00452	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000394	0.0017	CcSEcCtD
Propylthiouracil—Paraesthesia—Doxorubicin—uterine cancer	0.000388	0.00168	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—STK11—uterine cancer	0.000387	0.00444	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP19A1—uterine cancer	0.000387	0.00444	CbGpPWpGaD
Propylthiouracil—Somnolence—Doxorubicin—uterine cancer	0.000384	0.00166	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—uterine cancer	0.00038	0.00165	CcSEcCtD
Propylthiouracil—Urticaria—Epirubicin—uterine cancer	0.000371	0.0016	CcSEcCtD
Propylthiouracil—TPO—Metabolism—AKR1C1—uterine cancer	0.000371	0.00425	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Epirubicin—uterine cancer	0.000369	0.0016	CcSEcCtD
Propylthiouracil—DBH—Metabolism—RRM2—uterine cancer	0.000351	0.00403	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—uterine cancer	0.000343	0.00148	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—uterine cancer	0.000342	0.00148	CcSEcCtD
Propylthiouracil—DBH—Metabolism—DCN—uterine cancer	0.000341	0.00391	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—RRM2—uterine cancer	0.00033	0.00379	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—uterine cancer	0.00033	0.00143	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP11A1—uterine cancer	0.000321	0.00369	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—DCN—uterine cancer	0.000321	0.00368	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—uterine cancer	0.000306	0.00132	CcSEcCtD
Propylthiouracil—DBH—Metabolism—AKR1C3—uterine cancer	0.000304	0.00348	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP11A1—uterine cancer	0.000302	0.00347	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—uterine cancer	0.000297	0.00128	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—uterine cancer	0.000294	0.00127	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—uterine cancer	0.000294	0.00127	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—uterine cancer	0.000293	0.00127	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTHFR—uterine cancer	0.000291	0.00334	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKR1C3—uterine cancer	0.000285	0.00327	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—uterine cancer	0.000277	0.0012	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—uterine cancer	0.000275	0.00119	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—uterine cancer	0.000272	0.00118	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—uterine cancer	0.000272	0.00118	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—uterine cancer	0.000271	0.00117	CcSEcCtD
Propylthiouracil—Nausea—Doxorubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Propylthiouracil—DBH—Metabolism—STK11—uterine cancer	0.000236	0.00271	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP19A1—uterine cancer	0.000236	0.00271	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—STK11—uterine cancer	0.000222	0.00255	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP19A1—uterine cancer	0.000222	0.00255	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTHFR—uterine cancer	0.000178	0.00204	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTHFR—uterine cancer	0.000167	0.00192	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—uterine cancer	0.000162	0.00186	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—EP300—uterine cancer	0.000154	0.00177	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—uterine cancer	0.000114	0.00131	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—uterine cancer	9.89e-05	0.00113	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—EP300—uterine cancer	9.43e-05	0.00108	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—uterine cancer	9.33e-05	0.00107	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—uterine cancer	9.29e-05	0.00107	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EP300—uterine cancer	8.86e-05	0.00102	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—uterine cancer	6.97e-05	0.0008	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—uterine cancer	6.56e-05	0.000752	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—uterine cancer	5.7e-05	0.000654	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—uterine cancer	5.36e-05	0.000615	CbGpPWpGaD
